What's at stake for the next wave of coronavirus vaccines
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in
- We looked at how the next set of COVID-19 vaccine candidates are shaping up;
- A consolidation tsunami is headed for digital healthcare;
- We found 5 key takeaways from Bright Health's IPO filing.
As the rollout of three authorized vaccines continues here in the US, other drugmakers are still carrying on in their pursuits to arm the world with more effective shots.
The companies are now looking at approval by the end of 2021.
Meanwhile, Novavax, which is close to getting the green light from the Food and Drug Administration for its coronavirus
Can it finish what it started?
Novavax could have the 'best' COVID-19 shot, but new delays are raising questions about the $10 billion biotech's path to profits
The funding boom for healthcare startups is, as you might expect, not slowing down just yet.
Healthcare startups raised $31.6 billion in the first three months of 2021, CB Insights reports.
Megan Hernbroth broke down the six investors making the most bets on digital health startups. Surprise, surprise: Tiger Global's at the top of the list.
All the funding is turning into M&A activity.
Most recently - Ro said on Wednesday that it's buying Modern Fertility.
It's a case of a well-funded startup (
And Ro isn't the only one acquiring. Cedar last week said it's buying rival Ooda Health, and Grand Rounds in March said that it's buying telehealth startup Dr. On Demand.
We're calling it the start of a "consolidation tsunami."
Well-funded healthcare startups are snatching up smaller companies to keep growing. It's the start of a consolidation tsunami.
A lot of that growth is coming from acquisitions of other companies.
Of the five health insurance startups we've been tracking for the past few years-Alignment, Bright, Clover, Devoted, and Oscar-there's only one left that hasn't started the going-public process (as far as we know): Devoted Health.
We'll still be looking over insurance filings to see how Devoted is doing.
Even so, there's nothing quite like getting a look at a company's S-1 filing.
Health insurance startup Bright Health is going public. Its S-1 filing reveals its bonkers revenue growth, dealmaking spree, and a foray into clinics.
Allison DeAngelis and Andrew rounded up the fastest growing biotech companies.
- Allison broke down how to pitch a biotech venture fund that turns down 98% of startups.
- Patricia Kelly Yeo spoke to home-care operators, who tell her they're having a hard time finding workers in a tight labor market.
- Blake and finance reporter Samantha Stokes chronicled JPMorgan's latest attempt to disrupt healthcare, just three months after Haven folded.
- Dr. Catherine Schuster-Bruce has a great story on the potential for other mRNA medicines.
- Dr Pepper forced to give $100K prize to BOTH contestants after boos erupt following odd tie-breaker at SEC championship halftime contest
- BHEL among 5 bidders for Rs 58,000 cr deal to manufacture, maintain 200 Vande Bharat trains
- ChatGPT is a new AI chatbot that can find mistakes in your code or write a story for you
- Rupee falls 24 paise to 82.09/$ amid rising crude, foreign fund outflows
- City of Joy mourns the loss of Dominique Lapierre
- Sensex, Nifty50 open in the red amid negative global cues – TVS Motor, Adani Enterprises, HDFC among stocks to watch out for
- The science behind selling a dress to an Indian woman, according to the CEO of Latin Quarters
- All except three Indian sectoral indices have outperformed their US counterparts in 2022 so far